MedPath

A pilot study to evaluate the effect of TWO kinds of MEditation programs on Hwa-byung patients

Completed
Conditions
Hwa-byung (anger syndrome)
Mental and Behavioural Disorders
Depression
Registration Number
ISRCTN75740459
Lead Sponsor
Korea Health Industry Development Institute (Korea, South)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Male or female from 20 to 65 years old
2. Diagnosed as hwa-byung using hwa-byung SCID (Structured Clinical Interview for DSM-?W)
3. Written informed consent form taken
4. Has no problems with communication (reading, writing, listening, speaking etc)

Exclusion Criteria

1. Has a severe neuro or psychiatric disorder
2. Has a history of major neuro-psychiatric disorder (autism, learning disorder, mental retardation etc.)
3. If the patient was in need of regular medication or psychotherapy, had a change in medication or dose of anti-depressant, barbiturate, hormone therapy in the past month
4. Seriously irritable patient
5. Participated in any other clinical trial within last one month from the screening day
6. Had a regular mind-body relaxation training more than one month within last year including any kind of meditation, qigong, etc.
7. Cannot understand written informed consent form or follow this study because of mental retardation, mental or emotional problems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hwa-byung symptoms scale at baseline (before the treatment) and post treatment (after eight sessions of treatment).
Secondary Outcome Measures
NameTimeMethod
1. State-Trait Anger Expression Inventory (STAXI) (only 20 items in state anger and trait anger)<br>2. Hospital Anxiety and Depression Scale of Korea (HAD)<br>3. Korean version of Mindfulness Attention Awareness Scale (K-MAAS)<br>4. Korean version of Difficulties in Emotion Regulation Scale (K-DERS)<br>5. Self-Compassion Scale (SCS)<br>6. Acceptance and Action Questionnaire (AAQ)<br><br>Measured at baseline (before the treatment) and post treatment (after eight sessions of treatment).
© Copyright 2025. All Rights Reserved by MedPath